Executive Director, Clinical Development (MD), Inflammation and Immunology

Role: Executive Director, Clinical Development (Inflammation & Immunology), leading strategy and execution for complex asset portfolios, including Phase 3 and early indications. Responsibilities: develop TPP and CDP, shape clinical strategies across indications, lead cross-functional teams (clinical, regulatory, safety, biometrics, medical affairs), oversee clinical trial design, conduct, and reporting, and serve as the external scientific representative, engaging with regulators, key opinion leaders, and scientific forums. Qualifications: MD or DO with 8+ years in biopharma, with preferred expertise in immunology or benign hematology, and experience leading Phase 2/3 programs. Preferred: board certification in hematology/rheumatology, regulatory experience, strong leadership, and communication skills. High-Value: focus on inflammation and immunology, late-stage development, global regulatory interactions, cross-functional leadership, and external scientific representation. Work setup: not specified; position entails senior leadership responsibilities with external engagement.